High cutoff haemodialysis in myeloma cast nephropathy: further investigation is needed

Lancet Haematol. 2019 Jul;6(7):e347. doi: 10.1016/S2352-3026(19)30090-0.

Authors

Frank Bridoux¹, Sylvie Chevret², Jean-Paul Fermand³

Affiliations

¹ CHU Poitiers, Poitiers 86021, France. Electronic address: [email protected].
² Department of Biostatistics and Medical Information, Unite Mixte de Recherche 1153 (ECSTRA Team), Paris Diderot University, Hôpital Saint Louis, Paris, France.
³ Department of Hematology and Immunology, Hôpital Saint Louis, Paris, France.

PMID: 31244474
DOI: 10.1016/S2352-3026(19)30090-0

No abstract available

Publication types

Letter
Comment

MeSH terms

Bortezomib
Humans
Kidney Diseases*
Multiple Myeloma*
Renal Dialysis

Substances

Bortezomib